Sodium & Mitochondria: New Energy Role
- A new study reveals the critical role of sodium ions in how cells generate energy.
- Published in Cell, the study highlights that respiratory complex I, a key enzyme in mitochondria, transports sodium.
- The chemiosmotic hypothesis, which earned Peter Mitchell a Nobel Prize in 1978, explains how mitochondria synthesize ATP, the main energy source for cells.
Uncover the surprising link between sodium and cellular energy! A groundbreaking study reveals that sodium ions play a critical role in how cells generate energy, challenging previous understanding of mitochondrial function. Respiratory complex I within mitochondria actively transports sodium, a process vital for efficient energy production and linked to Leber’s hereditary optic neuropathy (LHON), a neurodegenerative disease.Discover how scientists are expanding the chemiosmotic hypothesis to include sodium’s impact on ATP synthesis, showing its essential contribution alongside proton gradients. This research opens doors to potential new therapies, with implications for other neurological conditions like Parkinson’s disease. For the latest on medical breakthroughs and their implications, News Directory 3 delivers. Discover what’s next in the quest to understand and treat devastating diseases!
Sodium Ions’ Crucial Role in Cellular energy Production Discovered
Updated June 24, 2025
A new study reveals the critical role of sodium ions in how cells generate energy. Researchers at the centro Nacional de Investigaciones Cardiovasculares (CNIC), leading the GENOXPHOS group, found that sodium is essential for efficient cellular energy production. The research included scientists from the Complutense University of Madrid, the Biomedical Research Institute at Hospital Doce de octubre, the David Geffen School of Medicine at UCLA, and Spanish research networks CIBERFES and CIBERCV.
Published in Cell, the study highlights that respiratory complex I, a key enzyme in mitochondria, transports sodium. This previously unknown activity is vital for cellular energy production. The discovery offers a molecular explanation for Leber’s hereditary optic neuropathy (LHON), a neurodegenerative disease linked to mitochondrial DNA defects. The study indicates that LHON stems from a specific defect in complex I’s ability to transport sodium and protons.
The chemiosmotic hypothesis, which earned Peter Mitchell a Nobel Prize in 1978, explains how mitochondria synthesize ATP, the main energy source for cells. This process relies on a proton gradient across the inner mitochondrial membrane.The new findings expand this model, showing that sodium ions also play a meaningful role.
José Antonio Enríquez and Pablo Hernansanz, CNIC scientists, led the team that demonstrated mitochondrial complex I exchanges sodium ions for protons, creating a sodium gradient alongside the proton gradient. This sodium gradient accounts for about half of the mitochondrial membrane potential and is essential for ATP production.
Enríquez said, “Sodium-proton transport activity was lost when we eliminated complex I in mice, but was maintained when we eliminated complex III or complex IV, confirming that sodium-proton transport is directly affected by the lack of complex I function.” The team’s experiments showed that complex I’s hydrogenase activity and sodium-proton transport, while self-reliant, are both crucial for cell function.
Hernansanz commented, “Our results demonstrate that mitochondria have a sodium-ion reservoir that is essential for their function and for resisting cellular stress.” Enríquez added that regulating this mechanism is a key aspect of mammalian biology.
Discussing potential LHON treatments, Enríquez noted that while drugs can replicate sodium transport across the inner mitochondrial membrane in isolated mitochondria, their clinical use is limited by toxic effects on sodium transport in the cell membrane. “The challenge now is to design drugs that act specifically in mitochondria without effecting other parts of the cell,” Enríquez said.
What’s next
Researchers suggest that defects in sodium-proton transport may also contribute to other neurodegenerative diseases, such as Parkinson’s, where complex I involvement has been observed. Further research is needed to explore the therapeutic potential of targeting sodium transport in these conditions.